Quiet on the insider front: nobody at Immunic, Inc. bought or sold IMUX shares at market prices this past year.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters. On the institutional side, 55 funds reported holding IMUX at the end of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Tardio Jason | COO | Buy | 12,512 | $0.79 | $10K | SEC |
| Jun 20, 2025 | Vitt Daniel | CEO | Buy | 15,000 | $0.77 | $12K | SEC |
| Jun 16, 2025 | Nash Duane | Chair | Buy | 20,000 | $0.83 | $17K | SEC |
| Jun 9, 2025 | Tardio Jason | COO | Buy | 12,512 | $0.79 | $10K | SEC |
| Jun 6, 2025 | Vitt Daniel | CEO | Buy | 15,000 | $0.77 | $12K | SEC |
| Jun 5, 2025 | Neermann Joerg | Director | Buy | 30,000 | $0.76 | $23K | SEC |
| Jun 5, 2025 | Neermann Joerg | Director | Buy | 70,000 | $0.77 | $54K | SEC |
| Jun 4, 2025 | Whaley Glenn | CFO | Buy | 45,000 | $0.71 | $32K | SEC |
| Jun 4, 2025 | Rudick Richard Alan | Director | Buy | 143,075 | $0.70 | $100K | SEC |
| Nov 13, 2024 | Rudick Richard Alan | Director | Buy | 87,300 | $1.15 | $100K | SEC |
| Feb 28, 2024 | Vitt Daniel | CEO | Buy | 14,000 | $1.31 | $18K | SEC |
| May 16, 2023 | Whaley Glenn | CFO | Buy | 5,000 | $1.75 | $9K | SEC |
There were no open-market insider trades in IMUX in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
55 investment managers reported holding IMUX in SEC Form 13F filings for Q2 2026.
No congressional trades in IMUX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).